What Dsiappoints Investors About Anaplan, Inc. (PLAN)

Anaplan, Inc. (NYSE:PLAN) could be among the worst stocks to invest in right now as the company shares are trading 3.84% or 1.53 points down from …

Anaplan, Inc. (NYSE:PLAN) could be among the worst stocks to invest in right now as the company shares are trading 3.84% or 1.53 points down from last closing price of $39.86, reaching $38.33 at last check. Any clue why there is so much of action in the PLAN stock? The share price has dropped in 3 of the last 5 days and is up 27.06% over the past week. It will be exciting to see whether the stock manages to continue decreasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -1,380,925 shares, and in total 243775 shares valued at $9.344 million were seen changing hands compared with 1.625 million shares valued at $64.761 million recorded at the previous session. You should take into consideration that a falling volume on lower prices shows the bearish trend but this is an early indication which means that the PLAN stock is near its bottom.

Anaplan, Inc. (PLAN) shares have notched a 3-month gain of about 27.06%, but has still advanced 50.19% year to date. By comparison, the stock sank 0% over the past 12 months, while it jumped 11.37% over the 1 month. The company’s market cap is around $4.84B, with its short interest ratio standing at 3.29%.

In the current trading session for PLAN, the stock witnessed two major price actions, it rose to a high of $39.5 and was down as much as $38.18 at one point. The high recorded is very low when compared to their 52-week high which is $20.37. The 52-week high is now at -8.09 distance from current price. Their recent low of $41.76 represents a 88.42% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for PLAN is $41.82, this is above the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.

The stock of Anaplan, Inc. earned $-1.03 per share in the trailing 12 months and has a P/E ratio of -37.21. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 19.64 and lower compared to the sector’s average of 33.99. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. PLAN also has P/S multiple of 19.36. This is greater versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 1.09x.

The company recorded an interesting insider sale transaction by the Insider on Apr 18, 2019. A Securities and Exchanges Commission filings show that Frank Calderoni sold a total of 149,188 PLAN shares that day for a sum of around $5,190,251. Anaplan, Inc. (PLAN) insiders have acquired 207,154 shares in the stock within the past three months. In total, individual insiders traded 358,062 shares in the business, which makes up 0.523% of 68,464,498 shares that were traded over a year. In the past 12 months, insiders have purchased 67,159,627 shares while the seller parted with 1,304,871 shares.

PLAN‘s last price was up 23.78% as compared to the average trading price of 50 days recorded at $30.97 while enlarging the period to 200 trading days, the average closing price was $38.05. At present, there are 121.54 million in the total number of common shares owned by the public and among those 101.84 million shares have been available to trade. The percentage of shares being held by the company management was 1.2% while institutions stake was 45.5%. The company has generated negative returns on equity over the last 12 months (0%). It managed to keep its gross profit margin at 72% over the past 12 months.

When assessing the full upside of the PLAN stock, there is another set of technicals that should be looked into and considered. Its 2.08% gain from moving average of $37.55 has brought about a positive sentiment when calculated over the last 20 days. The market has allocated a beta of 0 to the stock. With the beta been less than one, this implies that the company shares are theoretically less volatile than the market, something that the traders definitely are keeping an eye on.

Most of the analysts surveyed by Thomson/First Call think quite highly of Anaplan, Inc. — 7 analysts rate the stock as a buy with another 0 rating it strong buy. There are 4 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $34.3636 on shares of Anaplan, Inc. (NYSE:PLAN), which corresponds to 10.14% downside potential than its current market price of $38.33 and implies potential despite the recent drop in the price. However, their current target price has climbed from $33.3 a month ago and is up handily from the consensus target of $27.5556 a quarter ago.

Let’s briefly check the hedge fund interest towards PLAN stock. Advisor Group Inc. added position in the company after it grew 21.3% or 1,722 shares of its common stock. The hedge fund now owns 2,089 shares worth $80,071, SEC documents show. BlackRock Inc. shored up assets in the stock as 1133463 shares have been purchased, increasing its stake by 2.1% to 1,157,266 shares which are currently valued at $44,358,006. In addition, California State Teachers Retirement System recently reported that it now owns 27,548 shares making a total of $1,055,915 based on the recent price. This refelects a change of -22.3% in their ownership.

Related Posts:

  • No Related Posts

Traders Must Not Feel Shy To Buy These Stocks:: NXP Semiconductors NV(NXPI)

On 09-05-2019 (Thursday), Shares of NXP Semiconductors N.V., (NASDAQ: NXPI) displayed a difference of -1.15% after which it shut the day’ session …

Market capitalization (market cap) is the market value of a publicly traded company’s outstanding shares.

Market capitalization is equal to the share price multiplied by the number of shares outstanding. As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company’s net worth and is a determining factor in some forms of stock valuation.

Imperative Factors to Watch:

On 09-05-2019 (Thursday), Shares of NXP Semiconductors N.V., (NASDAQ: NXPI) displayed a difference of -1.15% after which it shut the day’ session at $100.33. The volume added upto 4116279 shares which compares with the average volume of 3.38M shares.

NXP Semiconductors N.V., a Netherlands based Company, belongs to Technology sector and Semiconductor – Broad Line industry. The shares of NXP Semiconductors N.V. was among the active stocks of the last exchanging sessions.

Technical Analysis:

The stock price moved with change of 17.51% to its 50 Day low spot and changed -7.54% contrasting with its 50 Day high point. NXPI stock is as of now appearing down return of -5.88% all through a week ago and saw bearish return of 2.81% in one month span. The execution of company 10.58% in three months and 21.08% throughout the previous a half year exchanging period.

Unpredictability:

The stock value instability stayed at 2.69% in recent month and ranges at 3.19% for the week. The Average True Range (ATR) is also a measure of volatility is presently sitting at 3.37. The stock touched its 52-Week High on -17.92 and 52-Week Low on 48.37. The firm demonstrates the market capitalization of $32.54B.

Important Results:

NXP Semiconductors N.V. has P/S value of 3.46% while its P/B esteem remains at 2.8%. Likewise, the company has Return on Assets of 9.9%, Return on Equity of 18.2% and Return on Investment of 13.7%. The company demonstrates Gross Margin and Operating Margin of 51.7% and 27.9% respectively.

Forward P/E of NXP Semiconductors N.V. is remaining at 11.18. Forward P/E is a measure of the price-to-earnings ratio using forecasted earnings for the P/E calculation for the next fiscal year.

Related Posts:

  • No Related Posts

STAAR Surgical (STAA) Upgraded at Zacks Investment Research

Quantum Capital Management grew its stake in STAAR Surgical by 45.8% during the first quarter. Quantum Capital Management now owns 72,655 …

STAAR Surgical logoZacks Investment Research upgraded shares of STAAR Surgical (NASDAQ:STAA) from a hold rating to a strong-buy rating in a research note published on Tuesday morning, Zacks.com reports. The brokerage currently has $29.00 price target on the medical instruments supplier’s stock.

According to Zacks, “Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. “

Other equities analysts also recently issued reports about the stock. BidaskClub upgraded shares of STAAR Surgical from a hold rating to a buy rating in a research note on Wednesday, February 20th. Canaccord Genuity restated a buy rating and issued a $38.00 price target (down from $43.00) on shares of STAAR Surgical in a research note on Monday. Finally, ValuEngine upgraded shares of STAAR Surgical from a hold rating to a buy rating in a research note on Wednesday, May 1st. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. STAAR Surgical has a consensus rating of Buy and an average price target of $40.33.

Shares of STAA traded down $1.30 during trading hours on Tuesday, hitting $25.96. The company had a trading volume of 27,435 shares, compared to its average volume of 447,169. The firm has a market capitalization of $1.21 billion, a PE ratio of 91.82 and a beta of 2.02. STAAR Surgical has a 12 month low of $21.70 and a 12 month high of $54.00. The company has a debt-to-equity ratio of 0.04, a current ratio of 5.41 and a quick ratio of 4.83.

STAAR Surgical (NASDAQ:STAA) last issued its quarterly earnings data on Wednesday, May 1st. The medical instruments supplier reported $0.10 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.04 by $0.06. The company had revenue of $32.58 million for the quarter, compared to analyst estimates of $32.40 million. STAAR Surgical had a net margin of 4.44% and a return on equity of 13.22%. During the same period in the prior year, the firm earned $0.01 earnings per share. Analysts predict that STAAR Surgical will post 0.33 earnings per share for the current fiscal year.

In other STAAR Surgical news, CTO Keith Holliday sold 2,084 shares of the stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $36.22, for a total transaction of $75,482.48. Following the sale, the chief technology officer now directly owns 40,239 shares in the company, valued at $1,457,456.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Broadwood Partners, L.P. acquired 100,000 shares of STAAR Surgical stock in a transaction on Friday, May 3rd. The shares were purchased at an average price of $22.23 per share, for a total transaction of $2,223,000.00. The disclosure for this purchase can be found here. Insiders sold 17,730 shares of company stock worth $655,538 over the last 90 days. 3.90% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in the business. Great West Life Assurance Co. Can grew its stake in STAAR Surgical by 46.8% during the first quarter. Great West Life Assurance Co. Can now owns 5,172 shares of the medical instruments supplier’s stock worth $176,000 after buying an additional 1,649 shares in the last quarter. Cadence Capital Management LLC grew its stake in STAAR Surgical by 66.7% during the first quarter. Cadence Capital Management LLC now owns 113,410 shares of the medical instruments supplier’s stock worth $3,877,000 after buying an additional 45,387 shares in the last quarter. Quantum Capital Management grew its stake in STAAR Surgical by 45.8% during the first quarter. Quantum Capital Management now owns 72,655 shares of the medical instruments supplier’s stock worth $2,484,000 after buying an additional 22,809 shares in the last quarter. Victory Capital Management Inc. acquired a new stake in STAAR Surgical during the first quarter worth about $186,000. Finally, Comerica Bank grew its stake in STAAR Surgical by 7.5% during the first quarter. Comerica Bank now owns 37,197 shares of the medical instruments supplier’s stock worth $1,377,000 after buying an additional 2,600 shares in the last quarter. Hedge funds and other institutional investors own 90.99% of the company’s stock.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.

Read More: What is a resistance level?

Get a free copy of the Zacks research report on STAAR Surgical (STAA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for STAAR Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for STAAR Surgical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Broadcom Inc. (AVGO) stock price at $304.06 to 0.22% and 20 day SMA of -3.15%

Broadcom Inc. (AVGO) stock is growing 0.22% to $304.06. … Broadcom Inc. (AVGO) recently closed with fall of -3.15% to its 20-Day “SMA”. This short …

Broadcom Inc. (AVGO) stock go up so far this year; showing a rise of 19.58% and dropped with negative flow of -3.72% during recent week. The shares price has positioned 13.00% up over the past quarter while it has directed 38.15% toward a rising position throughout past six months. The shares price has directed 27.30% toward a higher level throughout last year and swapped 0.20% toward a strong spot during past one month.

Broadcom Inc. (AVGO) stock is growing 0.22% to $304.06. AVGO exchanged 2.23 million shares in recent session versus to the average volume of 2.48 million shares while its relative volume is 0.88. The company holds 397.64 million outstanding shares and 384.74 million shares are floating in market.

EPS in next five year years is expected to touch 15.61% while EPS growth in past 5 year was 39.60% along with sales growth of 52.60% in the last five years. EPS growth in next year is estimated to reach 14.23% while EPS growth estimate for this year is set at 187.60%.

The PE ratio of 26.40 helps investors explore how much they should pay for a stock based on its current earnings. High ratio reveals positive future performance and investors are willing to pay more. Low ratio discloses poor current and future performance. The price earnings ratio (P/E) ratio helps investors analyze how much they should pay for a stock based on its current earnings. The ROA is 11.40%. A company that manages their assets well will have a high return, while if manages their assets poorly will have a low return. ROI is 13.20%. A positive result means that returns exceed costs. Analysts therefore consider the investment a net gain. The opposite kind of result, a negative means that costs outweigh returns. Analysts therefore view the investment as a net loss.

Experts have a mean recommendation of 2.00 on this stock. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.

20-Day Simple Moving Average:

Broadcom Inc. (AVGO) recently closed with fall of -3.15% to its 20-Day “SMA”. This short time frame picture represents a downward movement of current price over average price of last 20 days. 20-day simple moving average is useful at identifying swing trading trends lasting 20 days.

50-Day Simple Moving Average:

50-day “SMA” is more useful at showing position trading trends lasting 50 days. Shares of AVGO moved upward with change of 1.99% to its 50-day Moving average. This rising movement shows positive prices direction over last 50 days.

200-Day Simple Moving Average:

200-day “SMA” is more helpful at telling general investing trends lasting 200 days. Longer moving average timeframes are less sensitive to price fluctuations than shorter term timeframes and will generate far few signals. This will reduce the number of “whipsaws”, which is good, but will also generate signals later than when using shorter term averages. AVGO stock price revealed optimistic move of 19.78% comparing average price of last 200 days. This comparison showed up direction of price above its 200-SMA.

The beta factor is 0.69. Volatility shows sense of how far the stock will fall if the market takes a dive and how high stock will rise if the bull starts to climb. A stock with a beta more than 1 means high volatile and less than 1 means low volatile.

Edgar gives us an insight into the most recent news hitting the Technology Sector in Wall Street Market. He has been an independent financial adviser for over 10 years in the city and in recent years turned her experience in finance and passion for journalism into a full-time role. He performs analysis of Companies and publicizes valuable information for shareholder community.

Edgar is an accomplished journalist who has a passion for travel. His desire to see the world has taken him to countries around the world and given him the opportunity to report for some of the top news organizations.

Related Posts:

  • No Related Posts

Analysts Set Lattice Semiconductor Corp (LSCC) PT at $11.80

Shares of Lattice Semiconductor Corp (NASDAQ:LSCC) have been assigned a consensus recommendation of “Buy” from the twelve brokerages that …

Lattice Semiconductor logoShares of Lattice Semiconductor Corp (NASDAQ:LSCC) have been assigned a consensus recommendation of “Buy” from the twelve brokerages that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $11.80.

Several brokerages recently commented on LSCC. BidaskClub downgraded shares of Lattice Semiconductor from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Rosenblatt Securities reaffirmed a “buy” rating and issued a $14.50 target price on shares of Lattice Semiconductor in a research note on Monday, April 29th. raised shares of Lattice Semiconductor from a “neutral” rating to a “positive” rating and lifted their target price for the stock from $8.00 to $11.00 in a research note on Wednesday, February 13th. Zacks Investment Research downgraded shares of Lattice Semiconductor from a “buy” rating to a “hold” rating in a research note on Thursday, February 14th. Finally, raised shares of Lattice Semiconductor from a “neutral” rating to a “positive” rating and lifted their target price for the stock from $8.00 to $11.00 in a research note on Wednesday, February 13th.

In other Lattice Semiconductor news, Director Mark Edwin Jensen sold 4,000 shares of the business’s stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $12.56, for a total transaction of $50,240.00. Following the transaction, the director now directly owns 67,434 shares of the company’s stock, valued at approximately $846,971.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Byron Wayne Milstead sold 41,911 shares of the business’s stock in a transaction on Monday, February 25th. The shares were sold at an average price of $12.32, for a total transaction of $516,343.52. Following the transaction, the vice president now directly owns 54,296 shares in the company, valued at $668,926.72. The disclosure for this sale can be found here. Over the last three months, insiders have sold 85,180 shares of company stock worth $999,721. Insiders own 0.78% of the company’s stock.

A number of institutional investors have recently modified their holdings of LSCC. Pearl River Capital LLC purchased a new position in Lattice Semiconductor during the 4th quarter valued at $27,000. Meeder Asset Management Inc. boosted its holdings in shares of Lattice Semiconductor by 157.3% during the 1st quarter. Meeder Asset Management Inc. now owns 5,056 shares of the semiconductor company’s stock valued at $62,000 after buying an additional 3,091 shares in the last quarter. Stone Ridge Asset Management LLC bought a new stake in shares of Lattice Semiconductor during the 4th quarter valued at $72,000. Bank of Montreal Can boosted its holdings in shares of Lattice Semiconductor by 226.5% during the 1st quarter. Bank of Montreal Can now owns 6,099 shares of the semiconductor company’s stock valued at $73,000 after buying an additional 4,231 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Lattice Semiconductor during the 4th quarter valued at $81,000. 90.94% of the stock is currently owned by institutional investors and hedge funds.

Shares of LSCC stock traded down $0.01 during trading hours on Tuesday, hitting $13.65. 15,007 shares of the company’s stock were exchanged, compared to its average volume of 1,958,885. The company has a market capitalization of $1.80 billion, a PE ratio of 61.82, a price-to-earnings-growth ratio of 3.29 and a beta of 1.39. Lattice Semiconductor has a 12-month low of $5.37 and a 12-month high of $14.93. The company has a debt-to-equity ratio of 0.97, a quick ratio of 3.13 and a current ratio of 4.10.

Lattice Semiconductor (NASDAQ:LSCC) last issued its earnings results on Tuesday, April 30th. The semiconductor company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.01). Lattice Semiconductor had a positive return on equity of 15.95% and a negative net margin of 3.25%. The firm had revenue of $98.09 million during the quarter, compared to analysts’ expectations of $96.01 million. During the same period in the previous year, the firm earned $0.05 earnings per share. The firm’s quarterly revenue was down .5% compared to the same quarter last year. On average, research analysts predict that Lattice Semiconductor will post 0.36 EPS for the current year.

About Lattice Semiconductor

Lattice Semiconductor Corporation, together with its subsidiaries, develops and sells semiconductor technologies in Asia, Europe, and the Americas. The company offers field programmable gate arrays that consist of five product family lines, including the ECP, MachXO, iCE40, CrossLink, and programmable mixed signal devices.

Featured Article: Why is the price-sales ratio important?

Analyst Recommendations for Lattice Semiconductor (NASDAQ:LSCC)

Receive News & Ratings for Lattice Semiconductor Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Lattice Semiconductor and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts